List view / Grid view
8 January 2019 | By Sciex
A complete workflow to quantify intact therapeutic proteins in plasma matrix has been developed, covering three critical components in preclinical sample analysis: target protein enrichment/purification, LC/MS data acquisition and quantitative data analysis.
1 November 2018 | By Eurofins Amatsigroup
Frédéric Gaussens from Eurofins Amatsigroup (CDMO) giving an overview of the services they provide...
26 October 2018 | By European Pharmaceutical Review
Results from a Phase III clinical trial indicate that patients suffering from ankylosing spondylitis could benefit from the biologic drug ixekizumab...
24 October 2018 | By European Pharmaceutical Review
A market report has given a complete backdrop analysis of the pharmaceutical outsourcing market, including market growth and shares...
5 October 2018 | By Mike Stones
North America dominates the global market for pharmaceutical glass packaging, due to the region’s technical innovation and strong demand for pharmaceutical products...
24 September 2018 | By Roquette
Learn how Roquette supports customers in the development of innovative pharmaceutical formulations and new biopharma solutions...
17 August 2018 | By Charles River
The Burkholderia cepacia complex (BCC) species are a group of gram-negative, rod-shaped bacteria that have been shown in recent years to be of concern for patients, and thus for manufacturers of drugs and products that contribute to patient health...
27 July 2018 | By Bruker
The webinar describes how 2D NMR can offer protein biochemists unprecedented analytical precision. By assigning just one spectrum, users can obtain a unique fingerprint of a protein at an atomistic resolution. This non-destructive technique can also be combined with other complimentary techniques to gain even further insights into sample quality.…
19 July 2018 | By Mike Stones
The EU and Japan have agreed to widen the range of medicines for which they will recognise each other’s inspections of manufacturing sites.
12 June 2018 | By European Pharmaceutical Review
Shape-conforming hydrogel leverages the body's own healing mechanisms rather than releasing drugs or biologics...
5 June 2018 | By European Pharmaceutical Review
The U.S. Food and Drug Administration has approved Fulphila (pegfilgrastim-jmdb) as the first biosimilar to Neulasta to help reduce the risk of infection during cancer treatment.
23 May 2018 | By European Pharmaceutical Review
Researchers have developed a highly specific apoptosis assay designed for immunofluorescence microscopy analysis of fixed core needle biopsy specimens...
13 April 2018 | By European Pharmaceutical Review
In this In-Depth Focus; early biotherapeutic lead optimisation for more efficient drug discovery and development, and turning promising compounds into drug candidates.
1 March 2018 | By Dr Payam Behzadi
In parallel with the use of a wide range of antibiotics for treating infectious diseases worldwide, antimicrobial resistance has significantly increased. For this reason, the application of an advanced pangenomic technique like DNA microarray can be an effective, rapid, accurate, sensitive, specific and flexible methodology for detecting, identifying and determining…
5 February 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
Researchers have systematically analysed and quantified the interactions of all proteins with metabolites on the level of the whole proteome...
Follow: